Long-term effects of lung cancer computed tomography screening on health-related quality of life: The NELSON trial

European Respiratory Journal

Volumn 38, Issue 1, 2011, Pages 154-161

  Van Den Bergh, K A M ^a   Essink Bot, M L ^a,b   Borsboom, G J J M ^a   Scholten, E T ^c   Van Klaveren, R J ^a   De Koning, H J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c University of Amsterdam ^*  (Netherlands)

Author keywords

Computed tomography; Lung neoplasms; Mass screening; Quality of life

Indexed keywords

ADULT; ANXIETY; ARTICLE; CANCER SCREENING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISTRESS SYNDROME; EUROQOL QUESTIONNAIRE; FEMALE; FOLLOW UP; HUMAN; IMPACT OF EVENTS SCALE; LUNG CANCER; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATE TRAIT ANXIETY INVENTORY;

BELGIUM; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; NETHERLANDS; QUALITY OF LIFE; QUESTIONNAIRES; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 79960154114     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00123410     Document Type: Article

References (22)

1. Miller AB, Madalinska JB, Church T, et al. Health-related quality of life and cost-effectiveness studies in the European randomised study of screening for prostate cancer and the US Prostate, Lung, Colon and Ovary trial. Eur J Cancer 2001; 37: 2154-2160. (Pubitemid 33001284)
2. Byrne MM, Weissfeld J, Roberts MS. Anxiety, fear of cancer, and perceived risk of cancer following lung cancer screening. Med Decis Making 2008; 28: 917-925.
3. van den Bergh KA, Essink-Bot ML, Borsboom GJ, et al. Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON). Br J Cancer 2010; 102: 27-34.
4. van den Bergh KA, Essink-Bot ML, Bunge EM, et al. Impact of computed tomography screening for lung cancer on participants in a randomized controlled trial (NELSON trial). Cancer 2008; 113: 396-404.
5. Vierikko T, Kivistö S, Järvenpää R, et al. Psychological impact of computed tomography screening for lung cancer and occupational pulmonary disease among asbestos-exposed workers. Eur J Cancer Prev 2009; 18: 203-206.
6. Otto SJ, Schroder FH, de Koning HJ. Low all-cause mortality in the volunteer-based Rotterdam section of the European randomised study of screening for prostate cancer: self-selection bias? J Med Screen 2004; 11: 89-92. (Pubitemid 38829886)
7. Zeliadt SB, Etzioni R, Ramsey SD, et al. Trends in treatment costs for localized prostate cancer: the healthy screenee effect. Med Care 2007; 45: 154-159.
8. van Klaveren RJ, Oudkerk M, Prokop M, et al. Management of lung nodules detected by volume CT scanning. N Engl J Med 2009; 361: 2221-2229.
9. van Iersel CA, de Koning HJ, Draisma G, et al. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 2007; 120: 868-874. (Pubitemid 46175408)
10. Xu DM, Gietema H, de Koning H, et al. Nodule management protocol of the NELSON randomised lung cancer screening trial. Lung cancer 2006; 54: 177-184. (Pubitemid 44802721)
11. Essink-Bot ML, Stouthard ME, Bonsel GJ. Generalizability of valuations on health states collected with the EuroQolc-questionnaire. Health Econ 1993; 2: 237-246.
12. Gandek B, Ware JE, Aaronson NK, et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998; 51: 1171-1178. (Pubitemid 28527173)
13. Kind P, Brooks R, Rabin R, eds. EQ-5D Concepts and Methods: A Development History. Dordrecht, Springer, 2005.
14. Ware J Jr, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34: 220-233. (Pubitemid 126433231)
15. van der Bij AK, de Weerd S, Cikot RJ, et al. Validation of the Dutch short form of the state scale of the Spielberger State-Trait Anxiety Inventory: considerations for usage in screening outcomes. Community Genet 2003; 6: 84-87. (Pubitemid 37323446)
16. Maissi E, Marteau TM, Hankins M, et al. The psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: 6-month follow-up. Br J Cancer 2005; 92: 990-994. (Pubitemid 40546658)
17. BromD, Kleber RJ. De Schok Verwerkings Lijst [The Dutch version of the Impact of Event Scale]. Ned Tijdschr Psychol 1985; 40: 164-168.
18. Horowitz M, Wilner N, Alvarez W. Impact of event scale: a measure of subjective stress. Psychosom Med 1979; 41: 209-218. (Pubitemid 9219271)
19. Taylor KL, Shelby R, Gelmann E, et al. Quality of life and trial adherence among participants in the prostate, lung, colorectal, and ovarian cancer screening trial. J Natl Cancer Inst 2004; 96: 1083-1094. (Pubitemid 39172410)
20. Laaksonen M, Rahkonen O, Martikainen P, et al. Smoking and SF-36 health functioning. Prev Med 2006; 42: 206-209.
21. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003; 41: 582-592.
22. Turner D, Schunemann HJ, Griffith LE, et al. The minimal detectable change cannot reliably replace the minimal important difference. J Clin Epidemiol, 63: 28-36.